These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8383358)

  • 1. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
    Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
    Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
    Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
    Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor.
    Suzuki K
    FEBS J; 2010 May; 277(10):2223-9. PubMed ID: 20402764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
    España F; Estelles A; Griffin JH; Aznar J
    Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
    Laurell M; Stenflo J
    Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
    Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
    Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.
    Berg DT; Gerlitz B; Shang J; Smith T; Santa P; Richardson MA; Kurz KD; Grinnell BW; Mace K; Jones BE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4423-8. PubMed ID: 12671072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
    Chan AK; Patel S; Male C; Berry LR; Mitchell LG
    Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex.
    Bhiladvala P; Strandberg K; Stenflo J; Holm J
    Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
    Duranton J; Adam C; Bieth JG
    Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protein C and plasma serine protease inhibitors in patients with essential hypertension].
    Kłoczko J; Bielawiec M; Galar M; Czaczkowska T; Wojtukiewicz M
    Pol Tyg Lek; 1991 Dec 26-30; 46(50-52):974-6. PubMed ID: 1669185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.